Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Endo Health Solutions Inc (ENDP)  
$0.00 0.00 (0.00%) as of 4:30 Tue 4/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 230,290,000
Market Cap: 138.17(K)
Last Volume: 11,847,187 Avg Vol: 11,814,994
52 Week Range: $0.0001 - $0.055
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 825
  Page 27 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kelso Partners V L P 10% Owner   –       –       •   2005-10-13 4 OE $2.42 $130,746 I/I 49,931 17,246,015     -
   Kelso Equity Partners V L P 10% Owner   –       –       •   2005-10-13 4 OE $2.42 $141,749 I/I 54,133 18,697,157     -
   Endo Pharma Llc 10% Owner   –       –       •   2005-10-13 4 OE $2.42 $169,527 D/D 64,741 22,361,051     -
   Kelso Investment Assoc V L P 10% Owner   –       –       •   2005-10-13 4 OE $2.42 $141,749 I/I 54,133 18,697,157     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2005-10-12 4 S $26.04 $2,789,118 D/D (107,109) 72,801     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2005-10-12 4 OE $2.42 $525,426 D/D 179,910 179,910     -
   Lankau Peter A President & CEO   •       •      –    2005-10-12 4 S $26.04 $2,169,575 D/D (83,317) 56,795     -
   Lankau Peter A President & CEO   •       •      –    2005-10-12 4 OE $2.42 $404,924 D/D 140,112 140,112     -
   Black Jeffrey R Exec. V.P., CFO and Treasurer   •       –      –    2005-10-12 4 S $26.04 $40,660,314 D/D (1,561,456) 1,027,868     -
   Black Jeffrey R Exec. V.P., CFO and Treasurer   •       –      –    2005-10-12 4 OE $2.42 $7,203,489 D/D 2,589,324 2,589,324     -
   Lee David A H Exec. V.P and CSO   •       –      –    2005-10-12 4 S $26.04 $46,286,412 D/D (1,777,512) 1,174,537     -
   Lee David A H Exec. V.P and CSO   •       –      –    2005-10-12 4 OE $2.42 $8,267,668 D/D 2,952,049 2,952,049     -
   Ammon Carol A Director   –       •      –    2005-10-12 4 S $26.04 $116,467,363 D/D (4,472,633) 2,861,233     -
   Ammon Carol A Director   –       •      –    2005-10-12 4 OE $2.42 $19,557,996 D/D 7,333,866 7,333,866     -
   Hyatt Michael Director   –       •      –    2005-10-12 4 S $26.04 $2,334,798 I/I (89,662) 50,000     -
   Hyatt Michael Director   –       •      –    2005-10-12 4 S $26.04 $4,328,291 D/D (166,217) 400,000     -
   Connors James J Ii 10% Owner   –       –       •   2005-10-12 4 OE $2.42 $40,846,462 I/I 15,036,789 17,295,946     -
   Connors James J Ii 10% Owner   –       –       •   2005-10-12 4 S $26.04 $427,011,628 I/I (16,398,296) 32,332,736     -
   Connors James J Ii 10% Owner   –       –       •   2005-10-12 4 OE $2.42 $44,283,434 I/I 16,302,040 18,751,290     -
   Connors James J Ii 10% Owner   –       –       •   2005-10-12 4 S $26.04 $462,941,906 I/I (17,778,107) 35,053,329     -
   Kelso Partners V L P 10% Owner   –       –       •   2005-10-12 4 OE $2.42 $40,846,462 I/I 15,036,789 17,295,946     -
   Kelso Partners V L P 10% Owner   –       –       •   2005-10-12 4 S $26.04 $427,011,628 I/I (16,398,296) 32,332,736     -
   Endo Pharma Llc 10% Owner   –       –       •   2005-10-12 4 OE $2.42 $52,961,214 D/D 19,496,587 22,425,792     -
   Endo Pharma Llc 10% Owner   –       –       •   2005-10-12 4 S $26.04 $553,660,006 D/D (21,261,905) 41,922,379     -
   Kelso Equity Partners V L P 10% Owner   –       –       •   2005-10-12 4 OE $2.42 $44,283,434 I/I 16,302,040 18,751,290     -

  825 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 27 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed